ArticleBMC cardiovascular disorders2025
Multidisciplinary management of intravenous leiomyomatosis extending to the inferior vena cava and heart: a case series.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Uterine Leiomyomas with Intravenous Leiomyomatosis: A Report of Two Cases.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis study provides a concise review of the multidisciplinary management of intravenous leiomyomatosis (IVL) with inferior vena cava or intracardiac extension, based on cases from a tertiary teaching hospital in China.
methodsWe retrospectively analyzed nine patients diagnosed with intravenous leiomyomatosis(IVL)extending to the inferior vena cava or cardiac chambers between January 2015 and February 2025. Data included patient demographics, imaging findings, multidisciplinary collaboration, surgical details, and follow-up outcomes.
resultsMost patients with intravenous leiomyomatosis(IVL)presented with nonspecific symptoms; 77.78% had a history of uterine leiomyoma, and 55.56% had undergone myomectomy or hysterectomy. Key imaging modalities included Computed Tomography venography, echocardiography, pelvic Magnetic resonance imaging, and pelvic ultrasound. Surgery was the primary treatment: eight patients underwent single-stage surgery, one had two-stage surgery (1/9). Six patients presented with lesions extending into the cardiac chambers (6/9), Of these, three underwent combined inferior vena cava and cardiac incision surgery, while the remaining three had tumors extracted solely via an inferior vena cava incision. Intraoperative transesophageal echocardiography was utilized for real-time monitoring to ensure complete tumor resection. Intraoperative blood loss ranged from 400 to 5000 mL (median: 1200 mL, interquartile range: 3075mL); six patients required allogeneic transfusion. No postoperative complications occurred. During the follow-up period, four patients experienced recurrence and all underwent reoperation.
conclusionIntravenous leiomyomatosis (IVL) with inferior vena cava or intracardiac extension is complex and requires multidisciplinary management.Computed Tomography venography effectively delineates intravascular lesions, and intraoperative transesophageal echocardiography provides real-time monitoring. Complete tumor resection and oophorectomy are critical for preventing recurrence, but even with these, there is still a high rate of recurrence, and most of the recurrence requires another surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.